Homocysteine and lipid peroxidation products: Important atherosclerosis risk factors in renal allograft recipients?

Transplantation Proceedings

Volumn 32, Issue 6, 2000, Pages 1367-1368

  Serafinowicz, A ^a   Kukula K ^a   Cieciura, T ^a   Shaibani, B ^a   Bczkowska, T ^a   Soin, J ^a   Sadowska, A ^a   Nowacka Cieciura, E ^a   Lewandowska, D ^a   Rell, K ^a   Durlik, M ^a   Lao, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYALKEN; ALKENE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HOMOCYSTEINE; MALONALDEHYDE; UNCLASSIFIED DRUG;

ADULT; AMINO ACID METABOLISM; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY ALLOGRAFT; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; ALDEHYDES; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; KIDNEY TRANSPLANTATION; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MALONDIALDEHYDE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TIME FACTORS;

EID: 0033825112     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)01259-8     Document Type: Article

References (6)

1. Kang S.S., Wong P.W., Malinow M.R. Annu Rev Nutr. 12:1992;279.
2. Rolland P.H., Friggi A., Barlatier A., et al. Circulation. 91:1995;1161.
3. Kasiske B.L., Guijarro C., Massy Z., et al. J Am Soc Nephrol. 7:1996;158.
4. Arnadottir M., Hultberg B., Vladov V., et al. Transplantation. 15:1996;509.
5. Wilcken DEL, Dudman NPB: In: Lusis AJ, Rottert JI, Sparkes RS (eds): Genetic Factors in Atherosclerosis: Candidate Genes and Processes. Basel, Switzerland: Karger 1992, p 311.
6. Ubbink J.B., Vermaak W.J.H., van der Merwe A., et al. J Nutr. 124:1994;1927.